| Literature DB >> 30483219 |
Bing Han1, Yi Chen1, Jing Cheng1, Qin Li1, Chunfang Zhu1, Yingchao Chen1, Fangzhen Xia1, Ningjian Wang1, Yingli Lu1.
Abstract
Objective: China is experiencing the world's largest urbanization. There are two primary types of urbanization in China: rural-to-urban migration and in situ urbanization, represented by Zhejiang Shangyu (SY) and Jiangsu Nanjing (NJ), respectively. Our aim is to compare changes in the prevalence of metabolic disease between these two types of urbanization in China.Entities:
Keywords: BMI; NAFLD; blood glucose; occupation; physical activity; urbanization
Year: 2018 PMID: 30483219 PMCID: PMC6240687 DOI: 10.3389/fendo.2018.00665
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Comparison of glucose metabolism indexes in these two places.
| Overall | 5.82 ± 1.03 | 5.54 ± 1.65 | <0.001 | 5.37 ± 0.80 | 5.83 ± 1.05 | <0.001 | 1.60 ± 1.64 | 1.60 ± 1.26 | 0.918 |
| <40 | 5.35 ± 0.67 | 4.84 ± 0.43 | <0.001 | 4.97 ± 0.55 | 5.19 ± 0.38 | <0.001 | 1.64 ± 1.13 | 1.32 ± 0.78 | 0.004 |
| 40–50 | 5.61 ± 0.88 | 5.22 ± 1.33 | <0.001 | 5.20 ± 0.67 | 5.51 ± 0.75 | <0.001 | 1.60 ± 1.53 | 1.38 ± 0.90 | 0.059 |
| 50–60 | 5.93 ± 1.13 | 5.60 ± 1.75 | 0.002 | 5.52 ± 0.88 | 5.92 ± 1.13 | <0.001 | 1.66 ± 2.17 | 1.51 ± 0.91 | 0.284 |
| 60–70 | 6.01 ± 0.98 | 5.76 ± 1.67 | 0.010 | 5.49 ± 0.78 | 6.07 ± 1.09 | <0.001 | 1.51 ± 1.33 | 1.95 ± 1.76 | 0.000 |
| >70 | 6.25 ± 1.29 | 6.07 ± 2.17 | 0.390 | 5.62 ± 0.91 | 6.17 ± 1.20 | <0.001 | 1.59 ± 1.78 | 1.80 ± 1.43 | 0.629 |
| Men | 5.70 ± 1.13 | 5.77 ± 2.07 | 0.469 | 5.51 ± 0.82 | 5.97 ± 1.26 | <0.001 | 1.46 ± 1.75 | 1.39 ± 0.94 | 0.609 |
| Women | 5.92 ± 0.94 | 5.47 ± 1.48 | <0.001 | 5.26 ± 0.76 | 5.78 ± 0.97 | <0.001 | 1.71 ± 1.55 | 1.67 ± 1.34 | 0.608 |
FPG, fasting plasma glucose; HOMAIR, homeostasis model assessment of insulin resistance.
Comparison of blood lipids in these two regions.
| Overall | 2.67 ± 0.64 | 3.23 ± 0.80 | <0.001 | 1.53 ± 1.57 | 1.57 ± 1.07 | 0.004 | 1.48 ± 0.31 | 1.31 ± 0.32 | <0.001 | 5.08 ± 1.01 | 5.13 ± 1.45 | 0.231 |
| <40 | 2.42 ± 0.54 | 2.82 ± 0.62 | <0.001 | 1.33 ± 2.16 | 1.04 ± 0.58 | 0.060 | 1.44 ± 0.29 | 1.36 ± 0.31 | 0.011 | 4.66 ± 0.82 | 4.58 ± 1.09 | 0.442 |
| 40–50 | 2.59 ± 0.61 | 3.17 ± 0.69 | <0.001 | 1.51 ± 1.85 | 1.50 ± 1.34 | 0.915 | 1.46 ± 0.28 | 1.39 ± 0.32 | 0.010 | 4.95 ± 0.95 | 5.01 ± 1.00 | 0.452 |
| 50–60 | 2.85 ± 0.72 | 3.38 ± 0.82 | <0.001 | 1.65 ± 1.45 | 1.64 ± 1.08 | 0.920 | 1.51 ± 0.34 | 1.33 ± 0.33 | <0.001 | 5.39 ± 1.18 | 5.40 ± 1.82 | 0.863 |
| 60–70 | 2.70 ± 0.61 | 3.30 ± 0.87 | <0.001 | 1.53 ± 1.14 | 1.77 ± 1.08 | 0.220 | 1.50 ± 0.31 | 1.28 ± 0.32 | <0.001 | 5.14 ± 0.92 | 5.23 ± 1.53 | 0.323 |
| >70 | 2.65 ± 0.60 | 3.23 ± 0.79 | <0.001 | 1.58 ± 1.10 | 1.55 ± 0.72 | 0.302 | 1.47 ± 0.32 | 1.23 ± 0.32 | <0.001 | 5.06 ± 0.96 | 5.07 ± 1.01 | 0.923 |
| Men | 2.71 ± 0.68 | 3.16 ± 0.73 | <0.001 | 1.76 ± 2.06 | 1.82 ± 1.34 | 0.031 | 1.46 ± 0.34 | 1.20 ± 0.30 | <0.001 | 5.16 ± 1.09 | 5.11 ± 1.66 | 0.643 |
| Women | 2.63 ± 0.60 | 3.25 ± 0.82 | <0.001 | 1.35 ± 1.01 | 1.49 ± 0.95 | 0.000 | 1.50 ± 0.29 | 1.36 ± 0.32 | <0.001 | 5.02 ± 0.95 | 5.14 ± 1.37 | 0.027 |
LDL, low-density lipoprotein; TG, triglyceride; HDL, high-density lipoprotein; TC, total cholesterol.
Figure 1Comparison of NAFLD between SY and NJ. Proportions of normal, steatosis and fatty liver in total (A), males (B), and females (C). Proportions of normal (D), steatosis (E), and fatty liver (F) in different age groups in SY and NJ.
Anthropometric measures between these two places.
| Overall | 23.03 ± 3.23 | 25.39 ± 3.28 | <0.001 | 33.60 ± 3.12 | 33.77 ± 3.80 | 0.193 | 76.82 ± 8.86 | 82.77 ± 9.93 | <0.001 | 91.27 ± 6.77 | 95.55 ± 6.93 | <0.001 |
| <40 | 21.95 ± 3.29 | 23.89 ± 3.43 | <0.001 | 33.06 ± 3.19 | 33.06 ± 3.63 | 0.992 | 72.86 ± 9.08 | 76.60 ± 12.42 | 0.001 | 89.28 ± 6.51 | 93.12 ± 6.44 | <0.001 |
| 40–50 | 23.00 ± 3.04 | 24.89 ± 3.01 | <0.001 | 33.75 ± 3.11 | 33.44 ± 3.11 | 0.243 | 76.44 ± 8.21 | 79.22 ± 9.39 | <0.001 | 91.16 ± 5.91 | 94.55 ± 7.26 | <0.001 |
| 50–60 | 23.43 ± 3.10 | 25.54 ± 2.96 | <0.001 | 33.66 ± 3.10 | 33.81 ± 3.83 | 0.542 | 77.89 ± 8.55 | 83.08 ± 8.70 | <0.001 | 91.74 ± 6.34 | 95.51 ± 6.73 | <0.001 |
| 60–70 | 23.40 ± 3.24 | 26.05 ± 3.42 | <0.001 | 33.78 ± 3.00 | 33.98 ± 3.89 | 0.417 | 77.86 ± 8.74 | 85.30 ± 8.52 | <0.001 | 92.15 ± 7.32 | 96.57 ± 6.70 | <0.001 |
| >70 | 22.74 ± 3.45 | 25.77 ± 3.22 | <0.001 | 33.43 ± 3.28 | 34.35 ± 4.44 | 0.034 | 78.08 ± 9.26 | 87.50 ± 8.79 | <0.001 | 91.01 ± 7.70 | 97.14 ± 7.02 | <0.001 |
| Men | 23.15 ± 3.01 | 25.63 ± 3.03 | <0.001 | 35.02 ± 2.75 | 37.11 ± 4.11 | <0.001 | 78.67 ± 8.29 | 87.14 ± 9.70 | <0.001 | 91.33 ± 6.10 | 96.19 ± 5.95 | < 0.001 |
| Women | 22.94 ± 3.38 | 25.31 ± 3.35 | <0.001 | 32.48 ± 2.92 | 32.69 ± 2.98 | 0.130 | 75.38 ± 9.02 | 81.35 ± 9.59 | <0.001 | 91.23 ± 7.24 | 95.35 ± 7.21 | <0.001 |
BMI, body mass index; NC, neck circumference; WC, waist circumference; HC, hip circumference.
Liner regression analysis of metabolic indexs in NJ compared to SY.
| NJ (vs. SY) | 0.47 (0.40, 0.53) | 0.32 (0.25, 0.40) |
| NJ (vs. SY) | −0.32 (−0.42,−0.23) | −0.83 (−0.91,−0.76) |
| NJ (vs. SY) | 2.44 (2.21, 2.68) | 1.24 (0.99, 1.49) |
| NJ (vs. SY) | 2.812 (1.469, 4.155) | −0.106 (−1.657, 1.445) |
| NJ (vs. SY) | 0.537 (0.485, 0.589) | 0.534 (0.481, 0.587) |
| NJ (vs. SY) | 0.025 (0.008, 0.042) | −0.115 (−0.132, −0.098) |
| NJ (vs. SY) | −0.183 (−0.206,−0.160) | −0.206 (−0.229, −0.182) |
Model 1, Age, sex, location; Model 2, BMI, HbA1c, SBP, HDL, LDL, TG.
Figure 2Odds rate of various diseases in NJ. Prevalence of prediabetes, diabetes, overweight, obesity, and dyslipidemia in NJ were higher than SY.